Abstract
Practice guidelines for the treatment of youth with mental health problems tend to endorse integrating psychopharmacologic treatment with psychosocial interventions, such as psychotherapy and parent skills training. However, poor access to pediatric mental health specialists and inadequate training of primary care physicians in psychosocial interventions make it difficult for families to receive this standard of care. Large pediatric randomized, multicenter trials, including the Multimodal Treatment Study of ADHD (attention deficit hyperactivity disorder) [MTA] and the Treatment for Adolescents with Depression Study (TADS), have begun to identify specific advantages of multimodal treatment compared with psychopharmacology alone. Advantages of combined treatment include improvement of both symptoms and family functioning. More research is needed to determine effective and appropriate multimodal interventions for complex and severe pediatric mental illness. Advantages of multimodal treatment must be balanced with the treatment burden on the family system.
Similar content being viewed by others
References
Report of the Working Group on Psychotropic Medications for Children and Adolescents: psychopharmacological, psychosocial, and combined interventions for childhood disorders: evidence base, contextual factors, and future directions [online]. Available from URL: http://www.apa.org/pi/cyf/childmeds.pdf [Accessed 2008 Oct 15]
Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2007 Feb; 46(2): 267–83
Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2007 Jan; 46(1): 107–25
Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 2007 Nov; 46(11): 1503–26
Ma J, Lee KV, Stafford RS. Depression treatment during outpatient visits by U.S. children and adolescents. J Adolesc Health 2005 Dec; 37(6): 434–42
Leigh H, Stewart D, Mallios R. Mental health and psychiatry training in primary care residency programs: part II. What skills and diagnoses are taught, how adequate, and what affects training directors’ satisfaction? Gen Hosp Psychiatry 2006 May–Jun; 28(3): 195–204
Richardson LP, Lewis CW, Casey-Goldstein M, et al. Pediatric primary care providers and adolescent depression: a qualitative study of barriers to treatment and the effect of the black box warning. J Adolesc Health 2007 May; 40(5): 433–9
Kim WJ. Child and adolescent psychiatry workforce: a critical shortage and national challenge. Acad Psychiatry 2003 Winter; 27(4): 277–82
Foster EM, Jensen PS, Schlander M, et al. Treatment for ADHD: is more complex treatment cost-effective for more complex cases? Health Serv Res 2007 Feb; 42: 165–82
Vitiello B. An update on publicly funded multisite trials in pediatric psychopharmacology. Child Adolesc Psychiatric Clin N Am 2006; 15: 1–12
MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention deficit/hyperactivity disorder (ADHD). Arch Gen Psychiatry 1999a Dec; 56(12): 1073–86
March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA 2004 Aug; 292(7): 807–20
Greenhill LL, Abikoff HB, Arnold LE, et al. Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 1996 Oct; 35(10): 1304–13
Pelham WE, Hoza B. Intensive treatment: a summer treatment program for children with ADHD. In: Hibbs ED, Jensen PS, editors. Psychosocial treatments for empirically-based strategies for clinical practice. New York: American Psychological Association, 1996: 311–40
Conners CK, Epstein JN, March JS, et al. Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry 2001 Feb; 40(2): 159–67
Wells KC, Chi TC, Hinshaw SP, et al. Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol 2006 Aug; 74(4): 649–57
Patterson GR, Reid JB, Dishion TJ. Antisocial boys: Vol. 4. A social interactional approach. Eugene (OR): Castalia, 1992
Pierce EW, Ewing LJ, Campbell SB. Diagnostic status and symptomatic behavior of hard-to-manage preschool children in middle childhood and early adolescence. J Clin Child Psychol 1999 Mar; 28(1): 44–57
The MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 2004; 113(4): 754–61
The MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 2004; 113(4): 762–9
Jensen PS, Arnold LE, Swanson JM, et al. 3-year follow-up of the NIMH MTA Study. J Am Acad Child Adolesc Psychiatry 2007 Aug; 46(8): 988–1002
Molina BS, Flory K, Hinshaw SP, et al. Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry 2007 Aug; 46(8): 1028–40
Swanson JM, Hinshaw SP, Arnold LE, et al. Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry 2007 Aug; 46(8): 1003–14
The Treatment for Adolescents with Depression Study Team. Treatment for Adolescents with Depression Study (TADS): rationale, design, and methods. J Am Acad Child Adolesc Psychiatry 2003 May; 42(5): 531–42
March J, Silva S, Vitiello B, et al. The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks. J Am Acad Child Adolesc Psychiatry 2006 Dec; 45(12): 1393–403
Kennard B, Silva S, Vitiello B, et al. Remission and residual symptoms after short-term treatment in the treatment of adolescents with depression study. J Am Acad Child Adolesc Psychiatry 2006; 45(12): 1404–11
Hollon SD, Garber J, Shelton RC. Treatment ofdepression in adolescents with cognitive behavior therapy and medications: a commentary on the TADS project. Cogn Behav Pract 2005; 12(2): 149–55
March JS, Silva S, Petrycki S, et al. The Treatment for Adolescents with Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry 2007 Oct; 64(10): 1132–44
Hack S, Chow B. Pediatric psychotropic medication compliance: a literature review and research-based suggestions for improving treatment compliance. J Child Adolesc Psychopharmacol 2001 Spring; 11(1): 59–67
Acknowledgments
Dr G. Reeves’ work was supported by a grant from the National Institute of Mental Health (1K12RR023240-01). Dr B. Anthony’s work was supported by a grant from the National Institute of Mental Health (K23 MH01899).
The authors have no conflicts of interest that are directly relevant to the content of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reeves, G., Anthony, B. Multimodal Treatments versus Pharmacotherapy Alone in Children with Psychiatric Disorders. Pediatr-Drugs 11, 165–169 (2009). https://doi.org/10.2165/00148581-200911030-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00148581-200911030-00002